ICHNOS SCIENCES TO PRESENT AT THE 2022 JEFFERIES HEALTHCARE CONFERENCE
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, announced that...
Stay updated with breaking news from Ichnos Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, announced that...
Updated Presentation Date and TimeNEW YORK, June 7, 2022 /PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company devel...
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
/PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the...